// App-Quantinova.ai

OP170 : Clinical parameters do not predict thrombosis after implantation of bioresorbable vascular scaffolds, but introduction of a specific implantation strategy is associated with a significant reduction in its incidence

Researchers

Presenter

  • Cuculi F

Principal Investigators

  • Puricel S

  • Schmermund A

  • Weissner M

  • Obitz J

  • Jamshidi P

  • Eggebrecht H

  • Munzel T

  • Cook S

  • Gori T

Medical Centers

  • Department of Medical Oncology, Kantonsspital Graubuenden, Chur, Switzerland

  • Cardio Centrum Bethanien, Frankfurt, Germany

  • University Medical Center Mainz, Mainz, Germany

  • Hopital and University of Fribourg, Fribourg, Switzerland

Locations

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved